RNTX
Acadian Asset Management’s Rein Therapeutics, Inc. Common Stock RNTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $0 | Hold |
17
| – | – | ﹤0.01% | 1875 |
|
|
2025
Q1 | $0 | Hold |
17
| – | – | ﹤0.01% | 1845 |
|
|
2024
Q4 | $0 | Hold |
17
| – | – | ﹤0.01% | 2249 |
|
|
2024
Q3 | $0 | Hold |
17
| – | – | ﹤0.01% | 2390 |
|
|
2024
Q2 | $0 | Hold |
17
| – | – | ﹤0.01% | 1924 |
|
|
2024
Q1 | $0 | Hold |
17
| – | – | ﹤0.01% | 1824 |
|
|
2023
Q4 | $0 | Hold |
17
| – | – | ﹤0.01% | 1852 |
|
|
2023
Q3 | $0 | Hold |
17
| – | – | ﹤0.01% | 1888 |
|
|
2023
Q2 | $0 | Hold |
17
| – | – | ﹤0.01% | 1943 |
|
|
2023
Q1 | $0 | Hold |
17
| – | – | ﹤0.01% | 2008 |
|
|
2022
Q4 | $0 | Sell |
17
-327
| -95% | – | ﹤0.01% | 1939 |
|
|
2022
Q3 | $0 | Hold |
344
| – | – | ﹤0.01% | 1885 |
|
|
2022
Q2 | $0 | Hold |
344
| – | – | ﹤0.01% | 1894 |
|
|
2022
Q1 | $0 | Sell |
344
-84,930
| -100% | – | ﹤0.01% | 1841 |
|
|
2021
Q4 | $47K | Buy |
+85,274
| New | +$47K | ﹤0.01% | 1500 |
|
|
2021
Q2 | – | Sell |
-134,419
| Closed | -$192K | – | 2251 |
|
|
2021
Q1 | $192K | Buy |
134,419
+31,632
| +31% | +$45.2K | ﹤0.01% | 1514 |
|
|
2020
Q4 | $107K | Buy |
102,787
+62,083
| +153% | +$64.6K | ﹤0.01% | 1725 |
|
|
2020
Q3 | $53K | Buy |
+40,704
| New | +$53K | ﹤0.01% | 1844 |
|
|
2020
Q2 | – | Sell |
-15,884
| Closed | -$5K | – | 2360 |
|
|
2020
Q1 | $5K | Buy |
+15,884
| New | +$5K | ﹤0.01% | 1740 |
|